OCTOBER 16-18, 2019



October 17-19, 2018 | Boston, MA

Q&A with Intel's Ben Tan: the Intel® Health Application Platform

Q: What is your perspective on the role of technology in healthcare today?

Ben: Market trends include an increase in global telemedicine, and in the size of the overall market for emerging edge technologies. The trend is bolstered by programs that improve reimbursements for patients who are participating in remote care programs. The technology -- in terms of sensing, reporting, and securing the data-- is here. The market is being driven by the desire for cost savings, lowered readmission rates, and there are already programs in place to accelerate remote patient monitoring.

Q: What is IHAP?

Ben: Intel® Health Application Platform (IHAP) is a platform that securely connects medical peripherals to a health data cloud, typically an electronic medical records (EMR) system. It enables healthcare care providers to use analytics for early detection and monitoring for a multitude of medical conditions and is also a platform that can be used for elderly care.

Q: How is Intel technology facilitating the delivery of patient care?

Ben: The Intel HAP platform centers on sensing, securing, and servicing. Sensing refers to our ability to connect to discrete types of sensors. Because the IHAP product is a platform that relies on third-party medical peripherals and sensors, our job is to ensure that it uses a standardized interface to collect and relay to data for maximum compatibility. That, in turn, enables clinicians to address different acute or chronic conditions by deploying kits that address specific needs.

Securing relates to the ability to take that data from the sensors and to ensure that it is securely stored on the IHAP Platform until ready for use. Intel’s HAP solution is both cloud and EMR agnostic. We provide the tools for users to extract encrypted data from the local database, and to push it up into either a storage or analytics platform. This second factor, when it comes to data security, also ensures that data is only sent to an authorized platform, from device to cloud.

Serviceability is all about an ecosystem of partners of third-party service providers that we have developed to take the product to market. Intel is uniquely positioned with a hardware and service platform that connects healthcare providers to a wealth of ecosystem partners.

 Q: What scenarios is IHAP best suited for?

Ben: Two major use cases illustrate the IHAP solution suite. The first is in the health market. This is the ability to reduce readmissions, and for clinicians to monitor overall patient progress. For example, a patient may be given a kit with a number of peripherals for a specific condition for a time period.

The second market that we address with IHAP is in what we call the elder care market. The IHAP platform can monitor the well being of an elderly person, not just in terms of medical readings, but also activity levels. In many European countries, that gives the social welfare system a way to monitor how well an elderly person is fairing overall in their daily lives.

If you overlay the two, health and care, you have a lot of raw data to help determine the well-being of the elderly person. While the first use case, centered around health, is not necessarily confined to a certain age range, the second is specific to monitoring the health of seniors.

Q: How is IHAP being utilized by Intel’s ecosystem of partners?

Ben: Intel connects solution providers with end users in a B-B-C manner. For example, we worked with Flex, our exclusive design manufacturing partner, to push out our first generation of products to remote care service providers -- our ecosystem partners. Each remote care service provider typically bundles its own version of an IHAP-based system, and then sells into a health network. Overall, we have built an ecosystem of partners that enables us to deliver a mix of technologies and customized solutions.

Q: What makes IHAP a unique solution in the marketplace today?

Ben: It is an agnostic to the variety of different EMR and cloud systems out there. And we do not have any claims on the patient data generated using our platform. Our focal point is in connecting ecosystem partners that can develop customized, market-ready solutions. Most products out there serve a single purpose. By contrast, IHAP provides a greater degree of flexibility for a diverse range of healthcare applications.

Q: Looking ahead, how will Intel IoT impact the evolution of healthcare delivery systems?

Ben: With the first generation of IHAP products, we focused primarily on data collection, data security, and edge analytics. Now, that focus is evolving to include telehealth and teleconsultation. This takes advantage of the expertise Intel has in human-computer interaction. The future, in part, is going to focus on how we bring the clinician consulting right into the home. New technologies that Intel can bring to market, either by ourselves, or with partners, will enable a greater amount of “always-on” sensing capability. For example, technology that monitors how a patient is faring after having knee surgery.  This will go beyond putting a sensor on a patient’s leg, it will include data from how the person is moving and walking in the home

This an exciting time for us because there are a plethora of technologies that we have developed, co-developed, or invested in, that will help clinicians deliver healthcare closer to the home.


Ben Tan is Market Development Director for the Intel® Health Application Platform. Intel is the Partnering Sponsor of the 2018 Connected Health Conference,.

Secure Your Seat

Be a part of the conversation!


Register Today